Post IPO investors in Switzerland
Updated 16 Nov 2026
Venture funds
2 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Nextech Invest Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio. Zürich, Switzerland |
Health care, Biotech | Early stage venture, Late stage venture | 31% | 2 |
| 2 | Novartis Venture Fund Novartis Venture Fund focuses on novel therapeutics and platforms, with recent investments in Hepalink and FoRx Therapeutics. Basel, Switzerland |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 27% | 2 |
Table 1. Post IPO investors in Switzerland: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | •••@sosei.com | 877 28••• |
| HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | •••@hbmhealthcare.com | +41 41••• |
| UBS | Corporate venture arm | Zürich, Switzerland | •••@ubs.com | 41 44 ••• |
| VI Partners | Venture capital firm | Altendorf, Switzerland | •••@vipartners.ch | +41 41••• |
| Nextech Invest | Venture capital firm | Zürich, Switzerland | •••@nextechinvest.com | 41 (0)••• |
| responsAbility Investments AG | Fund of funds | Zürich, Switzerland | •••@responsability.com | +41 44••• |
| Partners Group | Private equity firm | Baar, Switzerland | •••@partnersgroup.com | 212 90••• |
| Pictet Private Equity Investors S.A. | Investment bank | Geneva, Switzerland | •••@pictet.com |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 18 of the 26 post ipo investors in Switzerland have a published email address, 13 a phone number and 26 a website.
- Novartis Venture Fund has the most recorded investments, 279, 75 of them as lead investor.
- 5 of them are investors in at least one company that closed its most recent round in the last 12 months.
- UBS is an investor in 3 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Circle Pharma's $92.5M Series E on 16 September 2026.
- Software is the most common sector across their 95 portfolio companies (51%).
- Private equity is the most common investment stage, recorded for 17 of them (65%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Post IPO investors in Switzerland
26 of 26, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Novartis Venture Fund | Corporate venture arm, Venture capital firm | Basel, Switzerland | Health care, Biotech | Hepalink, FoRx Therapeutics | 2 | 279 | 75 | 77 | •••@sosei.com | 877 28••• | |
| 2 | HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | Biotech, Health care | 4TEEN4 Pharmaceuticals, Sphingotec GmbH, Odyssey Therapeutics | 260 | 47 | 90 | •••@hbmhealthcare.com | +41 41••• | ||
| 3 | UBS | Corporate venture arm, Fund of funds | Zürich, Switzerland | Fintech, Hardware | SWISSto12, MerQube, Nasdaq Private Market | 3 | 157 | 53 | 53 | •••@ubs.com | 41 44 ••• | In the CSV |
| 4 | VI Partners | Venture capital firm | Altendorf, Switzerland | Health care, Biotech | L.E.S.S. | 1 | 111 | 26 | 22 | •••@vipartners.ch | +41 41••• | In the CSV |
| 5 | Nextech Invest | Venture capital firm | Zürich, Switzerland | Health care, Biotech | Circle Pharma, Atavistik Bio | 2 | 100 | 31 | 43 | •••@nextechinvest.com | 41 (0)••• | In the CSV |
| 6 | responsAbility Investments AG | Fund of funds, Private equity firm | Zürich, Switzerland | Fintech, Commerce | Koa Switzerland, Investree, ePaylater | 74 | 42 | 11 | •••@responsability.com | +41 44••• | In the CSV | |
| 7 | Partners Group | Private equity firm | Baar, Switzerland | Hardware, Artificial intelligence | Neara, Akur8, Sirion | 74 | 39 | 34 | •••@partnersgroup.com | 212 90••• | In the CSV | |
| 8 | dRx Capital | Corporate venture arm, Venture capital firm | Basel, Switzerland | Biotech, Health care | Dopavision | 31 | 4 | 8 | In the CSV | |||
| 9 | Pictet Private Equity Investors S.A. | Investment bank | Geneva, Switzerland | Artificial intelligence, Biotech | Unique AI, Harbinger Health, Red Date Technology | 30 | 4 | 6 | •••@pictet.com | In the CSV | ||
| 10 | Nice & Green SA | Investment bank, Private equity firm | Nyon, Switzerland | 29 | 26 | 20 | •••@nicengreen.ch | In the CSV | ||||
| 11 | Armada Investment AG | Family office, Private equity firm | Kusnacht, Switzerland | Energy, Fintech | Last Energy | 1 | 19 | 5 | 5 | •••@armada.com | +41 44••• | In the CSV |
| 12 | kineo finance | Venture debt fund | Basel, Switzerland | 15 | 7 | 0 | In the CSV | |||||
| 13 | DDM Group | Private equity firm | Baar, Switzerland | ClimateCamp | 5 | 3 | 2 | +41417••• | In the CSV | |||
| 14 | CERN | Government investment office, Pension fund | Geneva, Switzerland | 2 | 0 | 1 | In the CSV | |||||
| 15 | Genferberg Capital | Private equity firm, Venture capital firm | Zürich, Switzerland | 2 | 0 | 1 | •••@genferberg.ch | +41 44••• | ||||
| 16 | Corinth Investment | Private equity firm, Venture capital firm | Chur, Switzerland | 1 | 1 | 1 | ||||||
| 17 | Investment & Development One Holding SA | Angel group, Family office | Geneva, Switzerland | 1 | 1 | 0 | •••@id-oneholding.ch | |||||
| 18 | Patrimonium Asset Management | Private equity firm | Crissier, Switzerland | 1 | 1 | 1 | +41 58••• | In the CSV | ||||
| 19 | Clearance Ventures | Venture capital firm | Basel, Switzerland | 1 | 0 | 0 | •••@clearanceventures.com | +41 61••• | In the CSV | |||
| 20 | FivazImmoInvestSARL | Family office, Private equity firm | Neuchâtel, Switzerland | 0 | 0 | 0 | •••@fivazimmoinvestsarl.com | |||||
| 21 | Ibex Capital Partners | Private equity firm | Chatelaine, Switzerland | 0 | 0 | 0 | •••@ibexcap.ch | In the CSV | ||||
| 22 | Meye Asset Management | Startup accelerator, Angel group | Zürich, Switzerland | 0 | 0 | 0 | •••@managementasset.com | |||||
| 23 | Odano Invest | Family office, Private equity firm | Cham, Switzerland | 0 | 0 | 0 | ||||||
| 24 | Private International Consulting Group | Family office | Chardonne, Switzerland | 0 | 0 | 0 | •••@private-int-consulting.com | +41.22••• | In the CSV | |||
| 25 | Samarjeet Das Ray | Geneva, Switzerland | 0 | 0 | 0 | In the CSV | ||||||
| 26 | Top Swiss Investments | Family office, Hedge fund | Küsnacht, Switzerland | 0 | 0 | 0 | •••@top-invests.com |
Table 2. Post IPO investors in Switzerland: the first 26 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 26.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | UBS | Zürich, Switzerland | 3 | 26 | SWISSto12, MerQube, Nasdaq Private Market |
| 2 | Nextech Invest | Zürich, Switzerland | 2 | 5 | Circle Pharma, Atavistik Bio |
| 3 | Novartis Venture Fund | Basel, Switzerland | 2 | 20 | Hepalink, FoRx Therapeutics |
| 4 | VI Partners | Altendorf, Switzerland | 1 | 19 | L.E.S.S. |
| 5 | Armada Investment AG | Kusnacht, Switzerland | 1 | 2 | Last Energy |
Table 3. Post IPO investors in Switzerland: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco, United States | Series E | $92.5M | 2026-09-16 | $300.0M | Nextech Invest | 11 to 50 | 2012 |
| SWISSto12 | SWISSto12 designs, manufactures, and integrates radio frequency products for commercial and government customers. | Hardware | Renens, Switzerland | Series C | $70.0M | 2026-07-16 | $202.3M | UBS | 251 to 500 | 2011 |
| MerQube | MerQube provides technology for rules-based investment strategies and passive index design. | Fintech | San Francisco, United States | Series C | $30.0M | 2026-04-13 | $67.0M | UBS | 51 to 100 | 2019 |
| Atavistik Bio | Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. | Biotech | Cambridge, United States | Series B | $40.0M | 2026-03-05 | $260.0M | Nextech Invest | 11 to 50 | 2021 |
| Nasdaq Private Market | Nasdaq Private Market provides a marketplace where private companies, banks, brokers, and investors transact. | Fintech | San Francisco, United States | Series C | $37.6M | 2026-01-16 | $143.9M | UBS | 51 to 100 | 2013 |
| FoRx Therapeutics | FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. | Biotech | Basel, Switzerland | Series A | $50.0M | 2025-12-18 | $109.4M | Novartis Venture Fund | 11 to 50 | 2019 |
| Last Energy | Last Energy develops modular micro nuclear power plants to provide nuclear energy. | Energy | Austin, United States | Series C | $100.0M | 2025-12-16 | $164.0M | Armada Investment AG | 51 to 100 | 2019 |
Table 4. Post IPO investors in Switzerland: the 7 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 48 | 51% |
| Health care | 35 | 37% |
| Biotech | 31 | 33% |
| Fintech | 24 | 25% |
| Hardware | 18 | 19% |
| Artificial intelligence | 16 | 17% |
| Education | 3 | 3% |
| Commerce | 3 | 3% |
| Cybersecurity | 2 | 2% |
| Energy | 2 | 2% |
Table 5. Post IPO investors in Switzerland: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Post IPO investors | 26 | 100% |
| Private equity investors | 17 | 65% |
| Late stage investors | 16 | 62% |
| Early stage investors | 15 | 58% |
| Venture investors | 14 | 54% |
| Seed investors | 13 | 50% |
| Debt investors | 13 | 50% |
| Convertible note investors | 10 | 38% |
Table 6. Post IPO investors in Switzerland by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Investors | Share |
|---|---|---|
| Zürich | 5 | 19% |
| Basel | 4 | 15% |
| Geneva | 4 | 15% |
| Baar | 2 | 8% |
| Zug | 1 | 4% |
| Altendorf | 1 | 4% |
| Nyon | 1 | 4% |
| Kusnacht | 1 | 4% |
| Chur | 1 | 4% |
| Crissier | 1 | 4% |
| Neuchâtel | 1 | 4% |
| Chatelaine | 1 | 4% |
Table 7. Post IPO investors in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 1 | 4% |
| 2010s | 4 | 17% |
| 2000s | 11 | 46% |
| 1990s | 5 | 21% |
| 1960s | 1 | 4% |
| 1950s | 1 | 4% |
Table 8. Post IPO investors in Switzerland by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include post ipo investors and its headquarters is in Switzerland. On 16 November 2026 that is 26 investors.
- 18 rows carry an email address and 13 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 26 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 26 rows: 0 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many post ipo investors in Switzerland are on the list?
- 26, in the file dated 16 November 2026. 5 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 18 of the 26 carry an email address in the download and 13 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 26 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 26 rows, 18 firm email addresses and 13 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 12 of the 18 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.